Functional domains of human growth hormone necessary for the adipogenic activity of hGH/hPL chimeric molecules.
Genetic analysis through construction of chimeric genes and their transfection in mammalian cells could provide a better understanding of biological functions of native or modified proteins, and would allow the design of new gene constructs encoding peptides that mimic or block ligand interaction with target tissues. To identify the hGH domains responsible for induction of adipose differentiation we constructed hGH/hPL chimeric molecules using homologous DNA mutagenesis, since hGH, but not human placental lactogen (hPL), promotes adipose differentiation in mouse 3T3-F442A cells. We assayed their adipogenic activity in an autocrine/paracrine biological model consisting of transiently transfected 3T3-F442A cells with the chimeric constructs. Plasmid DNAs carrying these constructs were transfected into growing 3T3-F442A cells, and cultures were further maintained for 7 days to differentiate into adipocytes. Secretion of transfected hGH/hPL chimeric proteins into the medium was in the range of 5-25 ng/ml. Adipogenic activity was a property only of those chimeric proteins that contained hGH exon III together with either hGH exon II or hGH IV. Our results also suggest that hGH binding site-2 is composed of two structural subdomains: subsite 2A encoded by exon II of hGH and subsite-2B encoded by exon IV. We also suggest that full adipogenic activity requires the presence of binding site-1 and any of the subsites of binding site-2. This simple autocrine/paracrine biological model of gene transfection allows the analysis of specific biological activity of products encoded by modified genes.
Juárez-Aguilar
E
E
Department of Cell Biology, Centro de Investigación y de Estudios Avanzados del I.P.N., Apdo. Postal 14-740 Mexico, D.F. 07000, Mexico.
Castro-Muñozledo
F
F
Guerra-Rodríguez
N E
NE
Reséndez-Pérez
D
D
Martínez-Rodríguez
H G
HG
Barrera-Saldaña
H A
HA
Kuri-Harcuch
W
W
D016475:3T3 Cells; D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects; D000818:Animals; D001665:Binding Sites / Q000235:genetics; D002454:Cell Differentiation / Q000187:drug effects; D019382:Human Growth Hormone / Q000737:chemistry* / Q000235:genetics / Q000494:pharmacology*; D006801:Humans; D051379:Mice; D008958:Models, Molecular; D016296:Mutagenesis; D010928:Placental Lactogen / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology; D011487:Protein Conformation; D017434:Protein Structure, Tertiary / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology; D014162:Transfection
D011993:Recombinant Fusion Proteins; D019382:Human Growth Hormone; D010928:Placental Lactogen